Acquiring Company
Abbott Laboratories
Acquired Company
Bigfoot Biomedical, Inc.
Abbott ParkMilpitasManufacturingBiotechnologyHealth CareMedicalMedical DeviceBiotechnologyHealthcareHealth CareScience And EngineeringDescription
Abbott (NYSE: ABT) today announced it has completed the acquisition of Bigfoot Biomedical, a leader in developing smart insulin management systems for people with diabetes.
Quick answer
Abbott Laboratories is acquiring Bigfoot Biomedical, Inc., announced September 22, 2023. Abbott Laboratories is based in Abbott Park, Illinois, United States.
- Who acquired Bigfoot Biomedical, Inc?
- Abbott Laboratories agreed to acquire Bigfoot Biomedical, Inc. on September 22, 2023.
- How much did Abbott Laboratories pay for Bigfoot Biomedical, Inc?
- The deal value was not disclosed.
- What does Abbott Laboratories do?
- Abbott Laboratories is a global healthcare company that develops and manufactures a wide range of health care products.
- Where are Abbott Laboratories and Bigfoot Biomedical, Inc. based?
- Abbott Laboratories is based in Abbott Park, Illinois, United States. Bigfoot Biomedical, Inc. is based in Milpitas, California, United States.
- Who are the decision-makers at Abbott Laboratories?
- Fundz holds 5 contacts at Abbott Laboratories. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Medical Device
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Airlife Completes Acquisition Of Avanos Medical’S Respiratory Health Business (October 2, 2023)
- Theken Companies Acquires Visionair Solutions (August 22, 2023)
- Caldera Medical Acquires Atlantic Therapeutics To Expand Portfolio In Women’S Health (September 6, 2023)
- Abbott To Acquire Bigfoot Biomedical, Furthering Efforts To Develop Personalized, Connected Solutions For People With Diabetes (September 5, 2023)
- Lilly To Acquire Point Biopharma To Expand Oncology Capabilities Into Next-Generation Radioligand Therapies (October 3, 2023)
- Xtant Medical Completes Acquisition Of Surgalign’S Hardware And Biologics Business (August 10, 2023)
Who to call at Abbott Laboratories, and when
When Abbott Laboratories changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Abbott Laboratories raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Abbott Laboratories, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Abbott Laboratories. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Abbott Laboratories makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Bigfoot Biomedical, Inc.?
Bigfoot Biomedical, Inc. was acquired by Abbott Laboratories, based in Abbott Park. The deal was reported on September 22, 2023. Abbott Laboratories is a global healthcare company that develops and manufactures a wide range of health care products. Abbott Laboratories is publicly traded (ABT) and operates in Manufacturing.
When did Abbott Laboratories acquire Bigfoot Biomedical, Inc.?
Abbott Laboratories's acquisition of Bigfoot Biomedical, Inc. was reported on September 22, 2023. Abbott (NYSE: ABT) today announced it has completed the acquisition of Bigfoot Biomedical, a leader in developing smart insulin management systems for people with diabetes. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Bigfoot Biomedical, Inc. do?
Developing an end-to-end Type 1 Diabetes Management System using simple design, cloud connectivity and human centered automation. It is privately held, operating in Biotechnology, and is based in Milpitas.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.